Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Eur J Cancer ; 43(10): 1581-9, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17446062

RESUMO

Central nervous system (CNS) atypical teratoid/rhabdoid tumours (AT/RT) are among the paediatric malignant tumours with the worst prognosis and fatal outcome. Insulin-like growth factor I receptor (IGF-IR) protects cancer cells from apoptosis induced by a variety of anticancer drugs and radiation. In the present study, IGF-IR was expressed in 8/8 primary AT/RT as detected by immunohistochemistry. Moreover, we found IGF-I and IGF-II mRNA in BT-16 CNS AT/RT cells and IGF-II mRNA in BT-12 CNS AT/RT cells, and autophosphorylated IGF-IR in both cell lines, indicating the potential presence of an autocrine/paracrine IGF-I/II/IGF-IR loop in CNS AT/RT. IGF-IR antisense oligonucleotide treatment of human CNS AT/RT cells resulted in significant down-regulation of IGF-IR mRNA and protein expression, induction of apoptosis, and chemosensitisation to doxorubicin and cisplatin. These studies provide evidence for the influence of IGF-IR on cellular responses to chemotherapy and raise the possibility that curability of selected CNS AT/RT may be improved by pharmaceutical strategies directed towards the IGF-IR.


Assuntos
Apoptose/efeitos dos fármacos , Neoplasias do Sistema Nervoso Central/tratamento farmacológico , Oligorribonucleotídeos Antissenso/uso terapêutico , Receptor IGF Tipo 1/efeitos dos fármacos , Tumor Rabdoide/tratamento farmacológico , Teratoma/tratamento farmacológico , Antineoplásicos/uso terapêutico , Neoplasias do Sistema Nervoso Central/patologia , Criança , Pré-Escolar , Cisplatino/uso terapêutico , Regulação para Baixo , Doxorrubicina/uso terapêutico , Feminino , Humanos , Lactente , Fator de Crescimento Insulin-Like I/metabolismo , Masculino , Receptor IGF Tipo 1/metabolismo , Tumor Rabdoide/patologia , Teratoma/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA